Fine Mark National Bank & Trust Iridex Corp Transaction History

Fine Mark National Bank & Trust

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$1.4 - $2.58 $54,600 - $100,620	-39,000 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$4.39 - $5.61 $1,602 - $2,047	-365 Reduced 0.93%	39,000 $177,000
Q1 2019 May 07, 2019	BUY	$4.14 - $5.18 $35,190 - $44,030	8,500 Added 27.54%	39,365 $180,000
Q4 2018 Feb 07, 2019	SELL	$3.85 - $6.3 $21,175 - $34,650	-5,500 Reduced 15.12%	30,865 $145,000
Q3 2018 Nov 02, 2018	SELL	$6.0 - $9.15 $27,900 - $42,547	-4,650 Reduced 11.34%	36,365 $231,000
Q2 2018 Aug 03, 2018	BUY	$5.33 - $7.24 $18,303 - $24,862	3,434 Added 9.14%	41,015 $285,000
Q4 2017 Jan 30, 2018	BUY	$7.62 - $9.94 $49,842 - $65,017	6,541 Added 21.07%	37,581 $286,000
Q3 2017 Oct 30, 2017	BUY	$8.19 - $10.25 $254,217 - $318,160	31,040	31,040 $291,000

3.25M

500

61.3K

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $22.2M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Fine Mark National Bank & Trust with notifications on news.